The severity and rapidity of acute, glutamate induced energy failure were compared in live cerebral cortical slices. In each experiment 80 live cerebral corti cal slices (350 f.Lm thick) were obtained from neonatal Sprague-Dawley rats, suspended and perfused in a nu clear magnetic resonance (NMR) tube, and studied at 4.7 mate exposure, lasted througout 30 additional min of glu tamate exposure and 60 additional min of washout with glutamate-free ACSF. Although dizocilpine did not alter the maximum decrease that occurred in PCr (to 36 ± 4% of control), dizocilpine did cause PCr levels to return to within 7 ± 5% of the control after 30 min of glutamate exposure. PCr levels stayed at this value throughout 30 additional min of glutamate exposure. During the wash out period PCr immediately rose to a value 5 ± 2% above the control and then remained constant during the rest of the 60-min washout. During the first 20 min of glutamate administration, kynurenic acid (1.0 mM) best improved the high-energy phosphate levels. NBQX (6.0 f.LM), re ported to protect the brain from ischemic injury, de creased PCr depletion during glutamate exposure without aff ecting the loss of ATP. After 60 min of glutamate wash out, PCr levels with kynurenate (84 ± 6% of control) and NBQX (84 ± 2% of control) were significantly higher (p < 0.001) than with glutamate alone (42 ± 6% of control), although ATP levels were not significantly improved by either drug. Acute energy failure in our brain slice model, intended to simulate oxygenated penumbral tissue, prob ably occurs primarily in neurons. The reason that dizo cilpine best preserves high-energy phosphate levels might relate to its mechanism of N-methyl-D-aspartate receptor blockade. Additional energy protection from dizocilpine might also arise from a partial blockade of voltage dependent Na + channels, which is possible at the con centration used.
T with interleaved 31pf1H NMR spectroscopy. NMR spectra, obtained continually, were determined as 5-min averages. Slices were perfused for 60 min with artificial cerebrospinal fluid (ACSF) containing either glutamate alone or glutamate mixed with one of three glutamate receptor antagonists: kynurenate, dizocilpine (MK-80l), and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxa line (NBQX). Dose-dependent decreases in high-energy phosphates were studied during glutamate exposure (0.5 to 10 mM), with and without antagonist protection. En ergy recovery after glutamate exposures was measured during a 6O-min washout with glutamate-free, antagonist free ACSF. Reversible and irreversible energy failures were characterized by changes in intracellular pH, and by changes in relative concentrations of ATP, phosphocre atine (PCr), and inorganic phosphate. No changes were observed in intracellular levels of N-acetylaspartate and lactate. Some special studies were also done using R-( -)-2-amino-5-phosphonovaleric acid (100 f.LM) and tetrodo toxin (1 mM) to examine glutamate receptor specificity in this tissue model. Dizocilpine (150 f.LM) best ameliorated the energy failure caused by 2.0 mM glutamate. With di zocilpine the maximum ATP decrease was only 6 ± 5%, instead of 35 ± 7%. Additionally, the dizocilpine-induced recovery of ATP levels, complete after 30 min of gluta-Neuronal death during hypoxia and ischemia ap pears to be caused by endogenous increases in brain extracellular glutamate (Choi and Rothman, 1990) . Glutamate excitotoxicity is also strongly implicated in certain neurological diseases associated with early neurodegeneration, dementia, seizures, and motor disturbances (Beal, 1992) . Impaired gluta mate uptake in synaptosomes made from postmor tem tissues of patients with amyotrophic lateral sclerosis has been reported recently (Rothstein et aI., 1992) . In a chemical toxin animal model of Par kinson's disease, neurotoxicity in the substantia ni gra was blocked by both competitive and noncom petitive N-methyl-D-aspartate (NMDA) antagonists (Klockgether et aI., 1991; Turski et aI., 1991) .
Ideally, direct testing of excitotoxic hypotheses would involve measuring excitatory amino acid (EAA) neurotransmitter concentrations and actions in synaptic spaces in vulnerable regions of the brain. Although synaptic glutamate concentrations are estimated to be in the millimolar range (Samson and Harris, 1992) , synaptic concentrations are not conveniently measurable. Indirect tests of excito toxic hypotheses are commonly performed in vivo and in live tissue preparations by studying cellular responses to augmented extracellular EAA concen trations during perturbations with and without re ceptor antagonists (Benveniste, 1991) .
One potentially informative cellular response linked to excessive glutamate receptor activation is an intracellular energy failure that is manifested by degradation of high-energy phosphorus metabo lites. Injury during glutamate toxicity might occur in the penumbra of ischemic brain tissue because of marginally inadequate energy substrate for ion ho meostasis and synaptic activity (Iijima et aI., 1992; Paschen et aI., 1992) . In one scenario, available ox ygen and glucose, potentially sufficient to sustain quiescent penumbral neurons, becomes insufficient when activation of glutamate receptor neurons causes increased ion transport and increased ATP utilization. Alternatively, glutamate toxicity in ischemic penumbral tissue is also alleged to arise from pathological processes associated with in creased intracellular calcium caused by activation Abbreviations used: ACSF, artifical cerebrospinal fluid; AMPA, a-amino-3-hydroxy-5-methyl-4-isoxazole propionate; ANOVA, analysis of variance; APV, R( -)-2-amino-5-phospho novaleric acid; CNQX, 6-cyano-2,3-hydroxy-7-nitroquinoxaline; EAA, excitatory amino acid; MK-801, +5-methyl-IO,1l-dihy droxy-5H-dibenzo[a,dlcyciohepten-5,IO-imine maleate; NAA, N-acetylaspartate; NBQX, 2,3-dihydroxy-6-nitro-7-sulfamoyl benzo(F)quinoxaiine; NMDA, N-methyl-D-aspartate; NMR, nu clear magnetic resonance, Pi' inorganic phosphate; PCr, phos phocreatine; PE, phosphoethanolamine; pHi' intracellular pH; RF, radiofrequency; TE, spin-echo delay; TTX, tetrodotoxin. Vol, 14, No, 2, 1994 of NMDA-type receptors (Simon and Shiraishi, 1990) .
Recent nuclear magnetic resonance (NMR) spec troscopy studies have demonstrated that measur able energy failure occurs in brain tissue very soon after excessive activation of NMDA-type glutamate receptors. In adult pig cerebral cortical slices ex posed to 10 ILM NMDA (Ben-Yoseph et aI., 1990), damage to energy metabolism was found early, be fore increases in free intracellular calcium concen trations and independent of the presence or absence of 1.2 mM Mg 2+ in the perfusion medium. In a dif ferent NMR spectroscopy study, where rat fore brain slices were exposed to 100 ILM NMDA for 0.5-3 min, high-energy phosphorus metabolites de clined rapidly, accompanied by a 0.3-pH unit acid ification of intracellular pH (pHi) and an increase in free lactate levels (Jacquin et aI., 1988 (Jacquin et aI., , 1989 . Ad ditionally, one non-NMR study found that de creased ATP in glutamatergic hippocampal neurons correlated with increased extracellular glutamate (Madl, 1992) , while another non-NMR brain slice study found that activation of NMDA-type recep tors was not a primary cause of glutamate-induced energy stress (Whittingham et aI., 1992) .
We decided to investigate intracellular energy failure in acute excitotoxic injury and performed a study having two general aims: (1) to characterize the rapidity and severity of acute, glutamate induced, intracellular energy failure; and (2) to de termine if protection from energy failure could be provided by one of three postsynaptic glutamate re ceptor antagonists-(a) kynurenic acid (Kessler et aI., 1989) , an endogenous tryptophan metabolite long known to antagonize EAA responses. (Kynurenate acts primarily by binding to the glycine regulatory site of NMDA-type receptors. However, it also binds nonspecifically to non NMDA-type receptors.); (b) dizocilpine, or MK-801 + 5-methyl-10, 11-dihydroxy-5H-dibenzo [a,d]cyclohepten-5,10-imine maleate (Wong et aI., 1986) , an antagonist that directly blocks the ion channel regulated by NMDA-type receptors; and (c) 2 ,3-dihydroxy-6-nitro-7 -sulfamoylbenzo(F)quin oxaline (NBQX), a potent non-NMDA receptor an tagonist (Sheardown et aI., 1990) .
Respiring cortical brain slices were chosen for study because they have a high concentration of both NMDA and non-NMDA glutamate receptors (Fagg and Matus, 1984; Monaghan and Cotman, 1989; Monyer et aI., 1992; Nakanishi, 1992 ) and be cause NMR spectroscopy studies of intracellular energy metabolism can be performed with numer ous methodological advantages over similar in vivo brain studies in live animals (Espanol et aI., 1992) .
Absolute concentrations of adenylates and phos phocreatine in respiring brain slices are -50% of those found in vivo, although phosphocreatine (PCr)/ATP ratios are the same in respiring slices as in vivo (Whittingham et aI., 1984) . Our use of a cylindrical NMR tube with live, perfused brain slices permitted (a) the total elimination of NMR signal contamination from nearby extracerebral re gions of soft tissue and muscle; (b) the selection of specific regions of the brain for study; (c) the con trol of extracellular fluid concentrations while main taining the functional integrity of molecular and cel lular structures found in vivo; (d) pharmacological interventions with controlled drug concentrations, without interference from the blood-brain barrier or hepatic metabolism; (e) the avoidance of complica tions due to systemic physiologic responses that oc cur in vivo; (0 the elimination of an anesthetic re quirement during experimental perturbations; and (g) higher NMR spectral resolution vis-a-vis whole body in vivo spectroscopy.
METHOD

Overall experimental design
The experimental design was as follows. (a) First, the dose dependence of glutamate-induced degradation of high-energy phosphorus metabolites was studied. The highest glutamate concentration, 2 mM, that would per mit 100% recovery of NMR metabolites with administra tion of glutamate receptor antagonists was found. At this concentration metabolite recovery did not occur if plain artificial cerebrospinal fluid (ACSF) was used after glu tamate exposure. (b) Next, high-energy phosphorus metabolite degradation by three NMDA and u-amino-3hydroxy-5-methyl-4-isoxazole propionate (AMPA) antag onists was studied in 120-min, glutamate-free investiga tions. A range of nontoxic doses was found for each antagonist. Preliminary experiments with different gluta mate concentrations were conducted with antagonist con centrations in the nontoxic range, and then the minimum protective antagonist concentration was chosen. (c) Sub sequently, studies were performed using the minimum protective concentration for each NMDA and AMP A re ceptor antagonist, with the 2 mM glutamate concentra tion. The purpose of the studies was to test whether syn aptic glutamate receptors were responsible for the ob served energy impairment. The resulting perturbations of pHj and high-energy phosphorus metabolites were then compared, using statistical measures described below. (d) A smaller number of studies with the same protocol were then done using R-( -)-2-amino-5-phosphonovaleric acid (APV), a highly selective NMDA receptor antagonist, to make qualitative comparisons with the effects caused by dizocilpine. (e) Because dizocilpine at high concentra tions has been known to block voltage-dependent Na + channels (Rothman, 1988; Allaoua and Chicheportiche, 1989; Halliwell et aI., 1989) , two studies were done using tetrodotoxin (TTX) (Yamasaki et aI., 1991; Stys et aI., 1992; Tasker et al., 1992) and the same protocol. The purpose of these studies was to test qualitatively if block-ade of voltage-dependent Na channels induced effects similar to those caused by dizocilpine.
Materials
Our ACSF contained a modified Kreb's balanced salt solution containing 124 mM NaCi, 5 mM KCI, 1.2 mM KH 2 P04, 1.2 mM MgS04, 1.2 mM CaCI 2 , 26 mM NaHC0 3 , and 10 mM glucose. It was prepared by the University of California San Francisco Cell Culture Fa cility, and administered after being warmed to 37°C and equilibrated with a 95% 0 2 /5% CO 2 gas mixture. When Mg 2 + -free ACSF was prepared the ionic composition was adjusted to obtain a serum osmolarity of =300 mOsm. Kynurenic acid was obtained from Sigma Chem ical Company (St. Louis, MO, U.S.A.). Dizocilpine (MK-80l) was graciously provided by Merck-Sharpe and Dohme. NBQX was graciously provided by Novo Nor disk (Copenhagen, Denmark). APV and TTX were ob tained from Research Biochemicals International.
Brain slice preparation
Details of our methods for performing interleaved 31PI IH NMR spectroscopy with live brain slices have been described elsewhere (Espanol et aI., 1992) . In this study, as in previous investigations, intracellular energy integ rity was assessed from determinations of pHj and from the relative concentrations of ATP, PCr, inorganic phos phate (PJ, phosphoethanolamine (PE), lactate, and N-acetylaspartate (NAA).
Neonatal rats were chosen for NMR brain slice studies primarily because detection of resonance peaks for intra cellular PE and perfusate Pj permits simultaneous deter mination of pHj and extracellular pH (Corbett et aI., 1987) . Additionally, neonatal brain slices are more toler ant than adult slices of prolonged alterations to the ionic . composition of perfusion media (Garthwaite and Garth waite, 1990) .
The protocol for obtaining brain slices was approved by the UCSF Committee on Animal Research. For each NMR study, 20 neonatal Sprague-Dawley rats (10-12 g, 7 ± 2 days old; Simonson, Gilroy, CA, U.S.A.) were killed by rapid decapitation. Within 30 s each brain was re moved from the cranial cavity and four cortical slices (=350 j.Lm thick) were obtained (39.8 ± 1.2 mg/slice), each having only one injured side, =50 j.Lm thick (Dingle dine, 1984) . Slices were obtained from the lateral surfaces of the left and right hemispheres by sliding the brain past a blade fixed 350 j.Lm above a flat, lubricated surface (McIlwain and Buddie, 1953; Chan and Fishman, 1978) . Recovery from postdecapitation ischemia was accom plished by immediately rinsing the slices twice with freshly oxygenated ACSF. The bicarbonate pH buffer for oxy-ACSF was maintained by continuous bubbling with a 95% 0 2 /5% CO 2 gas mixture that kept the Pc0 2 and ex tracellular pH constant (at 40 mm Hg and =7.4, respec tively). After rinsing the slices in fresh oxy-ACSF, they were immediately transferred to a 20-mm Wilmad NMR tube having a high cylindrical symmetry and a minimum magnetic inhomogeneity. Once in an NMR tube, an en semble of slices was perfused with fresh, oxy-ACSF at a flow rate of 15-20 mllmin and at a temperature of 37°C. The perfusion system included two Cole-Parmer peristal tic pumps fitted with quick-release pump heads to make up a complete nonrecirculating bleed and feed perfusion circuit that would not build up hydrostatic pressure inside the NMR tube. Extracellular fluid samples of perfusion medium were collected every 15 min from the entrance and exit of the NMR chamber and analyzed with a Radi ometer Model ABL 30 blood gas analyzer. 31p NMR spectroscopy was used to follow metabolic recovery of high-energy metabolite s-PCr , ATP, PE, and Pi-after postdecapitation ischemia. Metabolic recovery was al ways complete within 120 min.
NMR experiments
Interleaved 31p and lH spectra were obtained on a Nalorac Quest 4400 4.7-T NMR instrument, operating at 81 and 200 MHz, respectively. 31p and lH NMR spectra were collected before and during exposure to glutamate or to glutamate and NMDA antagonists [kynurenic acid, dizocilpine (MK-80l), and NBQX], as well as during the 6O-min reperfusion period. Magnetic field homogeneity was optimized by adjusting room-temperature shim cur rents until the water proton linewidth from the perfusate was less than 0.06 ppm. The 20-mm NMR tube containing 80 tissue slices was positioned inside a custom-made, double-tuned, four-turn, 23 x 15-mm solenoidal coil (Es panol et al., 1992) . Interleaved 31p/1H spectra of tissue slices were accumulated for 120 minutes after their isola tion to demonstrate that they recovered optimally from postdecapitation ischemia. The total acquisition time for interleaved 31p/1H spectra (Chang et aI., 1990; Xu et aI., 1991) was 5 min. Each acquisition consisted of 2048 com plex datum points for both 31p and lH. Time sharing was such that it took 0.84 s for a single 31p acquisition and 1.27 s for a single lH acquisition. Individual spectra for 31p and lH were generated after 60 acquisitions in the quadra ture-phase detection mode. The spectral width was ±3125 Hz. Typically, for 31p, the time duration of the radiofrequency (RF) excitation pulse was =27 J-lS for a 45° tip angle. The broad hump from phospholipids in the 31p spectra was removed by a convolution difference method.
Spin-echo lH NMR spectroscopy experiments were initiated with a 100-ms low-power pre saturation pulse centered on the water resonance and followed with a 1-1 RF pulse having frequency maxima and minima lo cated for selective excitation of metabolites with chemi cal shifts near lactate (1.32 ppm) and for selective none x citation of water (4.70 ppm) (Hetherington et aI., 1985; Williams et aI., 1992) . The spin-echo delay (TE) for refo cusing pulses was 136 ms (=1). Having a long spin-echo permitted substantial discrimination against more rapidly relaxing lipid signals that resonate near the lactate reso nance peak at 1.32 ppm. Because lactate is a doublet with splitting (111) of =7.3 Hz, choosing the TE to be an inte gral multiple of J caused lactate to have a maximally pos itive spectral amplitude. Refocusing pulses were phase cycled using the EXORCYCLE sequence (Bodenhausen et aI., 1977) . Other NMR spectroscopy parameters were as follows: 50 J-lS for a 90° nutation, a ±1,500-Hz spectral width, 2K datum points, a 500-ms repetition time, and an 862-ms interpulse delay. Each lH spectrum required 192 scans and =5 min of datum acquisition. Each lH spec trum was processed to achieve Lorenzian-to-Gaussian transformation by -12-Hz exponential and 7-Hz Gaus sian multiplication. Relative changes in intracellular lac tate levels were determined from lH spectra, using the NAA peak as an internal reference (Chang et aI., 1987) . Figures 1 and 2 quired (interleaved) 31p and lH NMR spectra from one study with 2 mM glutamate.
NMR signal intensities for each metabolite were deter mined by numerical integration of optimal computer fits to corresponding NMR resonance peaks in the spectra (Nalorac Quest 4400 Curve Fitting Program). 31p metab- olite concentrations were measured relative to corre sponding signal intensities in the control run. Relative ATP levels were determined from the J3-ATP peak at 16.3 ppm. Fully relaxed spectra (20-s interpulse delay) were obtained in special studies to obtain relaxation time corrections for different metabolites. Lactate signal inten sities were measured relative to those for NAA.
Glutamate studies
After recovery from postdecapitation ischemia, perfu sion of slices with well-oxygenated ACSF containing Mg 2 + was continued for another 30 min, and a control NMR spectrum was recorded. Immediately thereafter the perfusion medium was changed to ACSF free of Mg 2 + . After 30 min of equilibration, a 30-min set of Mg 2 + -free ACSF control NMR data was obtained. The use of Mg 2 + free ACSF was then continued during 60-min glutamate exposures, so that a maximum glutamate effect would be observed. However, Mg 2 + -containing ACSF was used during all 120-min metabolic recovery periods after glu tamate exposure, with or without an antagonist. Eighty-two separate NMR spectroscopy experiments were con ducted: (a) n = 6 control experiments for comparison of the effects of the absence (n = 3) and presence (n = 3) of Mg 2 + in ACSF; (b) n = 27 to measure the dose depen dence of glutamate responses [3 experiments x 6 gluta mate concentrations (0.5, 1.0, 2.0, 3.0, 5.0, and 10 mM glutamate) using ACSF with Mg 2 +; 3 experiments x 3 glutamate concentrations (0.5, 2.0, and 3.0 mM gluta mate) using ACSF without Mg 2 +]; (c) n = 36 antagonist dose-dependent responses [3 experiments x 3 antagonists (kynurenate, dizocilpine, and NBQX) x 4 concentrations of each antagonist] for studies at a 2 mM glutamate con centration; (d) n = 8 drug control experiments (2 x 4 antagonists) to determine metabolic responses of slices to dizocilpine, kynurenate, NBQX, or APV alone, in the absence of glutamate, and at the minimal antagonist con centration; and (e) n = 5 drug experiments to study met abolic responses of slices to APV (n = 3; 100 fLM) and TTX (n = 2; 1 mM).
Statistical/datum analysis
Data are reported as mean ± standard deviation. Statistical comparisons were made of average relative NMR metabolite values for different time points in the protocol. First, a repeated-measures analysis of variance (ANOV A) was used to determine if relative metabolite values appeared unchanged throughout time, i.e., consis tent with the null hypothesis (Winer, 1971 ). If the null hypothesis was rejected, multiple comparisons were made using Bonferroni-corrected t tests (Glantz, 1987) among the following a priori chosen time intervals (i.e., intervals chosen prior to taking data): (i) control, 0 min; (ii) at 20 min; (iii) at 30 min; (iv) at 60 min (at the com pletion of exposure to glutamate alone or to glutamate and antagonist); and (v) at 90 and 120 minutes (end of the 6O-min reperfusion period without glutamate). Details of our statistical methods have been described previously (Espanol et aI., 1992) .
RESULTS
Respiring brain slices remained viable during 12 h of perfusion with well-oxygenated ACSF containing either 1.2 roM or no Mg 2+ . At the end of 12 h of perfusion, the maximum time studied, there were no significant changes in relative levels of high energy phosphates, in lactate and NAA metabolite concentrations, or in pHi (=7.2).
Exposure to 0.5 roM glutamate caused no signif icant changes in high-energy phosphate levels when the ACSF contained 1.2 roMMg 2+ . However, high energy phosphate depletion occurred when gluta mate concentrations were higher, even in the pres ence of 1.2 roM Mg 2+ . Dose-dependent metabolic responses were found in slices exposed for 60 min to 1.0, 2.0, 3.0, 5.0, or 10 roM glutamate and then perfused with non-glutamate-containing ACSF for a 60-min washout period. Representative 31p NMR spectra in Fig. 1 show increased Pi and decreased pHi' PCr, and ATP at 30 and 60 min after exposure to glutamate. Figure 2 shows spectra illustrating that despite the changes in high-energy phosphates, there were no significant changes (p < 0. 001) in the lactatelNAA ratio (0. 69 ± 0.07). Figure 3A and B shows that during the time course of the studies, glutamate caused reductions in high-energy phos phates in a dose-dependent manner. At a 10 mM glutamate concentration, metabolic toxicity was seen without recovery, even in the presence of 1. 2 mM Mg 2+ . Additionally, the pHi decreased to 6.79 ± 0.07 during the first 30-min period of glutamate exposure from a control value of 7.17 ± 0.04 (Bon ferroni-corrected p < 0. 0002 for this difference), de spite the fact that the extracellular pH (medium pH) was stable at 7.43 ± 0. 09. No statistically significant decreases in pHi were observed at later times, for any glutamate concentration.
From the studies of glutamate dose dependence, a glutamate concentration of 2 mM was chosen for receptor antagonist studies. This turned out to be the lowest glutamate concentration having inc om- plete metabolite recovery with no treatment, and also the highest concentration having complete re covery with agonist treatment. Nontoxic concentration ranges for receptor an tagonists were determined in glutamate-free, dose dependent studies. (Each glutamate antagonist was found to be metabolically toxic at a sufficiently high concentration.) For kynurenate, concentrations of 0. 5 to 1.5 mM were found to be safe in glutamate free studies. For dizocilpine (MK-80l), nongluta mate studies showed no adverse responses to con centrations in the range 3{}-200 Il-M. NBQX was more potent, with glutamate-free concentrations tolerated in the range 3-24 Il-M. NBQX concentra tions above 24 Il-M were metabolically toxic. Mini mum antagonist concentrations chosen for each drug to provide maximal metabolic protection dur ing 2 mM glutamate exposure were 1 mM for kynurenate, 150 Il-M for dizocilpine, and 6 Il-M for NBQX. Figure 4 summarizes the protection provided dur ing and after 60 min of 2 mM glutamate exposure by the three glutamate receptor antagonists-kynuren ate (1 mM), dizocilpine (MK-801; 150 Il-M), and NBQX (6 Il-M). The plots show the average time courses of two NMR metabolites-PCr (Fig. 4A ) and ATP (Fig. 4B) . During 60 min of exposure to glutamate alone, deleterious changes occurred. PCr decreased to 38 ± 5% of the control, ATP de creased to 70 ± 3% of the control, and Pi increased to 108 ± 3% of the control (plot not shown). As shown in Fig. 4 , these were followed by minimal PCr recovery and transient ATP recovery during the 60-min washout with glutamate-free ACSF. During the first 20 min of glutamate administration PCr deterioration was reduced by kynurenic acid. Although, after 20-min exposure to 2 mM gluta mate, dizocilpine treatment did not change the de crease in PCr (which fell to 36 ± 4% of control; p < 0.001), it did prevent a substantial decrease in ATP (which fell only to 94 ± 5% of control; p < 0,001). Dizocilpine's action was more apparent 30 min after glutamate exposure began, when it caused a dra matic recovery of PCr (to 93 ± 5% of control; p < 0.001). During glutamate washout, ATP was 104 ± 6% of the control, while PCr rose to 106 ± 6% of the control.
Dizocilpine treatment resulted in the best recov ery profile for high-energy phosphates during gluta mate exposure and glutamate-washout. ATP and PCr levels after 60 min of glutamate washout were statistically different for the dizocilpine group com pared to the other groups (Bonferroni-corrected p < 0.008). ATP levels were not statistically different between the glutamate and the kynurenate groups (Bonferroni-corrected p < 0.50). However, ATP levels were significantly different between the kynurenate and the NBQX groups after 60 min of glutamate washout (Bonferroni-corrected p < 0.008). Measurements of relative chemical shift positions of the 13-1 and a-ATP peaks, accurate to ±0.05 ppm, revealed no detectable changes in intracellular Mg 2+ levels at any time in the protocol (p < 0.001), independent of the presence or absence of a 1.2 mM Mg 2+ or 2 mM glutamate concentration in ACSF. Figure 5 shows the results from special studies in which APV (100 fLM; n = 3 experiments) and TTX (1 mM; n = 2 experiments) were used instead of one of the three glutamate antagonists. Because of large statistical errors, the APV and TTX data in Fig. 5 are not significantly different from the data in Fig. 4 Time (min) different from the data for dizocilpine (p < 0.04), suggesting that dizocilpine's action might not be en tirely via blockade of NMDA-type receptors.
DISCUSSION
Our ex vivo 31p NMR cerebrocortical neonatal brain slice studies demonstrate that glutamate re ceptor activation is rapidly followed by the deteri oration of intracellular high-energy phosphorus me tabolites. The findings complement recent non NMR studies of glutamate-induced energy failure in hippocampal slices (Whittingham et al., 1992) . As in vivo, links between stimulus and response are not so easily explained. Interacting neurons and glia each have ionotropic and metabotropic glutamate receptors, although only neurons have NMDA-type receptors, and different, complex chains of events can connect receptor activation to mitochondrial damage and dysfunction. 
Time (min)
Previous studies of glutamate exposure in brain slices (Garthwaite and Garthwaite, 1991) and pri mary glial cultures (Giffard et aI., 1990 ) encourage us to speCUlate that observed irreversible high energy phosphorus changes occurred in neurons. A previous study of similarly prepared rat cortical brain slices, with 30--6 0 min of exposure to 1 mM glutamate, found the development of a 4% swelling, a 23% weight increase, and no significant ATP change. (Chan and Fishman, 1978; Chan et aI., 1979) A study of glutamate-induced astrocyte swell ing in cell cultures found recoverable swelling with glutamate concentrations of 0.1 and 1.0 mM but not with a glutamate concentration of 10 mM (Chan et al., 1990) . We therefore speculate that glial cells in our slice preparation were capable of recovering from the 2 mM glutamate exposure, with injured neurons accounting for the residual NMR-deter mined metabolite loss. Regrettably, our NMR spec troscopic information is neither cell specific nor sensitive to microheterogeneity. We cannot distin guish mild, uniform, partial energy depletion in both for APV and n = 2 complete brain slice stud-140 ies for nx. Data points are shown as mean ± standard deviation. Glutamate data are the same as in Fig. 4 neurons and glia from nonuniform, substantial en ergy depletion in neurons alone. Interestingly, some NMR methodologies are capable of distinguishing neuronal metabolism from glial metabolism. How ever, these NMR studies cannot be performed in living tissue. Perchloric acid tissue extracts must be studied with high-resolution NMR spectroscopy (Lapidot and Gopher, 1991) .
The early, transient protection provided to PCr by kynurenate and to ATP by NBQX in this proto col might be due to the drugs reaching effective levels more quickly in the interstitium (and syn apses) of the slices. Future studies might best avoid such pharmacokinetic issues by using protocols in volving pretreatment-where all antagonists have ample time to diffuse to effector sites prior to glu tamate exposure. The 30-min delay before dizo cilpine's dramatically protective action might simi larly be due to pharmacokinetics. However, a phar macodynamic property might also be involved, as dizocilpine's mechanism of action requires NMDA gated calcium ion channels to open and then be blocked in the transmembrane region (Huettner and Bean, 1988) . Dizocilpine' s superior protection might also be found in actions unrelated to calcium channels. At high dose levels dizocilpine has been shown to block voltage-dependent N a + channels (Rothman, 1988; Allaoua and Chicheportiche, 1989; Halliwell et aI., 1989) . Although our studies with TTX and APV do not provide strong evidence for high-energy phosphate protection during glutamate exposure, it is nevertheless possible that synergistic effects could occur in our model from action at re ceptors for both types of ion channels.
Because neuroprotection by NBQX during isch emia has been demonstrated in vivo (Nellgard and Wieloch, 1992) , we were initially disappointed that NBQX did not show greater metabolic protection in this normoxic brain slice study. After some reflec tion, however, it now seems that our expectations were naive and unrealistic. In our slice model all cells are exposed to substantial glutamate concen trations, and neurons are especially likely to benefit from noncompetitive blocking agents such as dizo cilpine. Noncompetitive blockers such as dizo cilpine function without having to fight against high levels of glutamate or, as in the case of kynurenate, against high levels of glycine. Although noncompet itive blockade of NMDA-type glutamate-regulated ion channels might be desirable in neural tissue when high glutamate levels occur, direct ion chan nel blockage might be more toxic in vivo to neurons after glutamate concentrations subside and ion channel function is again required. Because meta bolic rates of oxygen and glucose consumption were not measured in our system, and because the injury layer in well-oxygenated slices already pro duces a substantial lactate signal, we are unable to link glutamate-induced energy failure to inadequate substrate supply. Thus glutamate-induced increases in metabolism in our neonatal slices could be re sponsible for energy failure.
Hypoxia/ischemia brain slice studies of cortical and non cortical regions are necessary for further testing of the issues raised in this discussion. Addi tionally, longer times for antagonist exposure and recovery might be necessary in slice experiments. In a study using cerebellar and hippocampal slices, degeneration of neurons, including Purkinje cells and pyramidal cells, persisted when 6-cyano-2,3hydroxy-7-nitroquinoxaline (CNQX), an AMPA re ceptor antagonist similar to NBQX (Honore et aI., 1989) , was included in the exposing medium (Garth waite and Garthwaite, 1991) . However, degenera tion was prevented when CNQX was included for 90 min of reperfusion recovery.
An important future goal for such brain slice NMR studies is to devise hypoxia/ischemia/toxicity protocols that permit early revelations of late out comes and investigations of adult brain slices. If metabolic outcome studies in short-duration ex vivo NMR studies can be designed to reveal measures predictive of in vivo outcome and histological dam age, then the slice model will be extremely useful for efficient screening of new drugs against stroke and neurodegeneration.
